Asthma Trial, Recruiting NCT07313904 Sponsor: First Affiliated Hospital of Ningbo University Condition: Asthma
Back to Asthma

Asthma Trial, Recruiting

NCT07313904
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People between 18 and 80 years old (including those aged exactly 18 or 80); any gender or race may be considered
  • People with no history of asthma, allergic bronchopulmonary aspergillosis (a lung condition caused by mold allergy), or other long-term breathing conditions
  • People with no history of allergic conditions, such as hay fever, eczema, or food allergies
  • People whose lung function test results are normal or close to normal
  • People whose blood test results are normal, including markers of inflammation and immune cell counts, and whose allergy test results for common triggers (such as dust mites, pet hair, cockroaches, mold, and pollen) are normal or close to normal

Who may not be able to join:

  • People who have asthma, bronchiectasis (damaged airways), chronic obstructive pulmonary disease, active tuberculosis, a blood clot in the lungs, lung cancer, a collapsed lung, coughing up blood, high blood pressure in the lungs, or scarring/inflammation of the lung tissue
  • People who have a serious illness affecting other parts of the body, such as a recent heart attack, stroke, severe uncontrolled high blood pressure, serious heart rhythm problems, heart failure, a large bulge in a major blood vessel, liver failure, kidney failure, blood disorders, or cancer — particularly if recently diagnosed or currently being treated
  • People who have taken antibiotics, antifungal medications, immune-suppressing drugs, chemotherapy-type medicines, or steroid hormones within the four weeks before joining the trial
  • People who have other medical reasons that would make the sputum induction test (a procedure to collect a mucus sample from the airways) unsafe for them (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +86-0574-87089878

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
First Affiliated Hospital of Ningbo University
Registry
ClinicalTrials.gov
Start date
23 July 2025
Est. completion
30 June 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Respiratory fungi

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov